Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PeP-RALP: Perioperative Propranolol in Robotic Assisted Laparoscopic Prostatectomy
NCT05679193Phase 2Completed
- Sponsor
- Oslo University Hospital
- Start
- Jan 2023
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of propranolol in prostate cancer (PCa), sponsored by Oslo University Hospital. Started Jan 2023; status: completed.
02
Drugs
propranolol
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT05679193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05679193.